58 related articles for article (PubMed ID: 20446578)
1. [Disorder of vascular smooth muscle cell and platelet function in diabetes].
Goto H; Watada H
Nihon Rinsho; 2010 May; 68(5):833-8. PubMed ID: 20446578
[TBL] [Abstract][Full Text] [Related]
2. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
Srivastava AK
Int J Mol Med; 2002 Jan; 9(1):85-9. PubMed ID: 11745003
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
Massi-Benedetti M; Federici MO
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S120-3. PubMed ID: 10522835
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of vascular smooth muscle cell migration.
Gerthoffer WT
Circ Res; 2007 Mar; 100(5):607-21. PubMed ID: 17363707
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of cardio-vascular complications of diabetes].
Grimaldi A; Heurtier A
Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
[TBL] [Abstract][Full Text] [Related]
6. Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia.
You B; Ren A; Yan G; Sun J
Diabetes; 2007 May; 56(5):1445-53. PubMed ID: 17325258
[TBL] [Abstract][Full Text] [Related]
7. Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster.
Sima A; Popov D; Starodub O; Stancu C; Cristea C; Stern D; Simionescu M
Lab Invest; 1997 Jul; 77(1):3-18. PubMed ID: 9251674
[TBL] [Abstract][Full Text] [Related]
8. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
9. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
Triggle CR
Timely Top Med Cardiovasc Dis; 2008 Feb; 12():E3. PubMed ID: 18392213
[TBL] [Abstract][Full Text] [Related]
10. G protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia.
Hashim S; Li Y; Anand-Srivastava MB
Cell Biochem Biophys; 2006; 44(1):51-64. PubMed ID: 16456234
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective prostacyclin signaling in vascular smooth muscle.
Fetalvero KM; Martin KA; Hwa J
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):109-18. PubMed ID: 17164138
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques.
Inoue K; Kawahara K; Biswas KK; Ando K; Mitsudo K; Nobuyoshi M; Maruyama I
Cardiovasc Pathol; 2007; 16(3):136-43. PubMed ID: 17502242
[TBL] [Abstract][Full Text] [Related]
13. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
[TBL] [Abstract][Full Text] [Related]
14. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
Colette C; Monnier L
Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
[TBL] [Abstract][Full Text] [Related]
15. The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.
Rudijanto A
Acta Med Indones; 2007; 39(1):36-43. PubMed ID: 17939209
[TBL] [Abstract][Full Text] [Related]
16. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
Walcher D; Babiak C; Poletek P; Rosenkranz S; Bach H; Betz S; Durst R; Grüb M; Hombach V; Strong J; Marx N
Circ Res; 2006 Nov; 99(11):1181-7. PubMed ID: 17068290
[TBL] [Abstract][Full Text] [Related]
17. Effect of plasma, serum and platelets from diabetics on DNA synthesis in cultured vascular smooth muscle cells.
Umeda F; Franks DJ; Sugimoto H; Halle JP; Hamet P
Clin Invest Med; 1985; 8(1):35-40. PubMed ID: 3987117
[TBL] [Abstract][Full Text] [Related]
18. [Intrinsic and extrinsic factors implicated in cell proliferation of vascular smooth muscle in hypertension and diabetes].
Hadrava V; Russo CR; Kruppa U; Lacourcière Y; Tremblay J; Hamet P
Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():31-7. PubMed ID: 2080891
[TBL] [Abstract][Full Text] [Related]
19. Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin.
Sun J; Xu Y; Dai Z; Sun Y
Mol Cell Endocrinol; 2009 Dec; 313(1-2):64-9. PubMed ID: 19723557
[TBL] [Abstract][Full Text] [Related]
20. Buddleja officinalis suppresses high glucose-induced vascular smooth muscle cell proliferation: role of mitogen-activated protein kinases, nuclear factor-kappaB and matrix metalloproteinases.
Lee YJ; Kim JS; Kang DG; Lee HS
Exp Biol Med (Maywood); 2010 Feb; 235(2):247-55. PubMed ID: 20404041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
